By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Elekta AB (publ)

Elekta AB (publ) (EKTAY)

OTC Market Data in USD, Fundamentals in SEK
$4.93
+$0.03
+0.51%
Last Update: 29 Aug 2025, 19:48
$1.88B
Market Cap
776.55
P/E Ratio (TTM)
5.12%
Forward Dividend Yield
$4.36 - $7.13
52 Week Range

EKTAY Stock Price Chart

Explore Elekta AB (publ) interactive price chart. Choose custom timeframes to analyze EKTAY price movements and trends.

EKTAY Company Profile

Discover essential business fundamentals and corporate details for Elekta AB (publ) (EKTAY) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Medical - Instruments & Supplies

IPO Date

3 Mar 2009

Employees

4.54K

CEO

Jonas Bolander

Description

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity, a MR-Linac technology; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for advanced image-guided radiation therapy; treatment management solutions; automated and integrated quality assurance solutions; and hardware and software motion management technology. It also provides MOSAIQ Plaza for multidisciplinary cancer care; Elekta Axis Cloud, a managed hosting service; Elekta Studio, an image-guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the radiation oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Geneva, an applicator for cervical cancer treatment. In addition, the company offers Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for neurosurgeons; Leksell Gamma Knife Lightning for accelerated radiosurgery. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System or minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.

EKTAY Financial Timeline

Browse a chronological timeline of Elekta AB (publ) corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 28 May 2026

Upcoming earnings on 5 Mar 2026

Upcoming earnings on 26 Nov 2025

Earnings released on 28 Aug 2025

EPS came in at $0.03 .

Dividend declared on 24 Jul 2025

A dividend of $0.13 per share was announced, adjusted to $0.13. The dividend will be paid on 26 Sept 2025.

Earnings released on 28 May 2025

EPS came in at $0.11 falling short of the estimated $0.13 by -15.38%, while revenue for the quarter reached $535.86M , missing expectations by -89.93%.

Dividend declared on 7 Mar 2025

A dividend of $0.11 per share was announced, adjusted to $0.11. The dividend was paid on 27 Mar 2025.

Earnings released on 21 Feb 2025

EPS came in at $0.08 falling short of the estimated $0.09 by -11.11%, while revenue for the quarter reached $418.48M , missing expectations by -17.49%.

Earnings released on 27 Nov 2024

EPS came in at $0.06 .

Dividend declared on 9 Sept 2024

A dividend of $0.11 per share was announced, adjusted to $0.11. The dividend was paid on 27 Sept 2024.

Earnings released on 28 Aug 2024

EPS came in at $0.04 , while revenue for the quarter reached $361.74M .

Earnings released on 5 Jun 2024

EPS came in at $0.11 , while revenue for the quarter reached $462.62M .

Earnings released on 29 Feb 2024

EPS came in at $0.08 , while revenue for the quarter reached $432.97M .

Dividend declared on 26 Feb 2024

A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 18 Mar 2024.

Earnings released on 30 Nov 2023

EPS came in at $0.09 , while revenue for the quarter reached $426.17M .

Dividend declared on 25 Aug 2023

A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 15 Sept 2023.

Earnings released on 24 Aug 2023

EPS came in at $0.06 , while revenue for the quarter reached $358.53M .

Earnings released on 25 May 2023

EPS came in at $0.15 , while revenue for the quarter reached $495.80M .

Earnings released on 24 Feb 2023

EPS came in at $0.08 , while revenue for the quarter reached $413.49M .

Dividend declared on 24 Feb 2023

A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 17 Mar 2023.

Earnings released on 24 Nov 2022

EPS came in at $0.05 , while revenue for the quarter reached $368.22M .

Dividend declared on 26 Aug 2022

A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 16 Sept 2022.

Earnings released on 25 Aug 2022

EPS came in at $0.02 , while revenue for the quarter reached $325.04M .

Earnings released on 25 May 2022

EPS came in at $0.12 , while revenue for the quarter reached $428.48M .

Dividend declared on 25 Feb 2022

A dividend of $0.12 per share was announced, adjusted to $0.12. The dividend was paid on 18 Mar 2022.

Earnings released on 24 Feb 2022

EPS came in at $0.07 , while revenue for the quarter reached $392.34M .

Earnings released on 25 Nov 2021

EPS came in at $0.12 , while revenue for the quarter reached $430.95M .

Dividend declared on 26 Aug 2021

A dividend of $0.13 per share was announced, adjusted to $0.13. The dividend was paid on 16 Sept 2021.

Earnings released on 25 Aug 2021

EPS came in at $0.04 , while revenue for the quarter reached $436.02M .

Earnings released on 31 Jul 2021

EPS came in at $0.04 , while revenue for the quarter reached $349.42M .

Dividend declared on 19 Apr 2021

A dividend of $0.11 per share was announced, adjusted to $0.11. The dividend was paid on 10 May 2021.

Earnings released on 25 Feb 2021

EPS came in at $0.10 surpassing the estimated $0.09 by +11.11%, while revenue for the quarter reached $427.48M .

Earnings released on 26 Nov 2020

EPS came in at $0.11 , while revenue for the quarter reached $397.33M .

EKTAY Stock Performance

Access detailed EKTAY performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run